Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2000
11/28/2000CA2091243C Recombinant acc synthase
11/28/2000CA2066428C Structural alterations of the egf receptor gene in human gliomas
11/28/2000CA1341148C Methods and compositions for the preparation of treponema pallidum antigens, including purified antigens and dna sequences coding therefor
11/23/2000WO2000070099A2 Differential gene expression in specific regions of the brain in neurodegenerative diseases
11/23/2000WO2000070092A1 Expression of ets-domain proteins in cancer
11/23/2000WO2000070089A1 Cdx2 is downstream mediator of apc tumor suppressor activity
11/23/2000WO2000070076A1 Tm4sf receptors
11/23/2000WO2000070071A1 Adenovirus derived gene delivery vehicles comprising at least one element of adenovirus type 35
11/23/2000WO2000070069A1 Acquired resistance genes in plants
11/23/2000WO2000070065A1 PROMOTER OF THIOREDOXINE TaTrxh2 IN WHEAT
11/23/2000WO2000070054A1 Pathogen-resistant grape plants
11/23/2000WO2000070052A1 Gene isolated from ricinus communis encoding a new protein that interacts with the oleate 12-hydroxylase enzyme
11/23/2000WO2000070051A1 NEUROPROTECTIVE PROPERTIES OF GDF-15, A NOVEL MEMBER OF THE TGF-β SUPERFAMILY
11/23/2000WO2000070049A2 Extracellular signaling molecules
11/23/2000WO2000070047A2 Full-length molecules expressed in human tissues
11/23/2000WO2000070046A2 Secreted polypeptides and corresponding polynucleotides
11/23/2000WO2000070042A1 143 human secreted proteins
11/23/2000WO2000070040A1 Cell concentration and lysate clearance using paramagnetic particles
11/23/2000WO2000070036A2 Genes expressed in hippocampus
11/23/2000WO2000070028A1 Sphingosine kinase enzyme
11/23/2000WO2000070022A2 Ex vivo expansion of mammalian hematopoietic stem cells
11/23/2000WO2000070021A2 Differentiated human embryoid cells and a method for producing them
11/23/2000WO2000070019A2 Process of rapid variety-independent plant transformation
11/23/2000WO2000070015A2 Cultures of insect cells which reproduce at 37 °c, method for obtaining said cultures and their uses
11/23/2000WO2000069913A1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS
11/23/2000WO2000069908A1 Interaction between the vhl tumour suppressor and hypoxia inducible factor, and assay methods relating thereto
11/23/2000WO2000069901A2 Proteins with insulin-like activity useful in the treatment of diabetes
11/23/2000WO2000069898A2 Molecular interactions in allergy cells
11/23/2000WO2000069897A2 Modulation of glgf motif (dhr/pdz) containing proteins interaction with cd3n in t lymphocytes
11/23/2000WO2000069896A2 Molecular interactions in haematopoietic cells
11/23/2000WO2000069895A2 Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins
11/23/2000WO2000069891A2 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins
11/23/2000WO2000069888A1 Self-assembling biomolecular structures
11/23/2000WO2000069884A2 Compositions isolated from skin cells and methods for their use
11/23/2000WO2000069883A1 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene
11/23/2000WO2000069470A2 Improved cellular uptake of bioactive agents
11/23/2000WO2000069468A1 Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
11/23/2000WO2000069463A1 Compositions and methods for treating cell proliferation disorders
11/23/2000WO2000069462A1 Human monoclonal antibody
11/23/2000WO2000069449A2 Conditioned cell culture medium compositions and methods of use
11/23/2000WO2000069355A1 Bioengineered anterior cruciate ligament
11/23/2000WO2000069257A2 Genetic modification of male germ cells for generation of transgenic species and genetic therapies
11/23/2000WO2000046375A3 Methods for producing polypeptides in fungal cells
11/23/2000WO2000043410A3 Novel odorant receptors in drosophila
11/23/2000WO2000042560A3 Methods for making character strings, polynucleotides and polypeptides
11/23/2000WO2000040615A3 EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS
11/23/2000WO2000037685A9 Method of identifying a psychotropic agent using differential gene expression
11/23/2000WO2000037608A3 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
11/23/2000WO2000036092A3 METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION
11/23/2000WO2000036090A3 Human brain endothelial cells and growth medium and method for expansion of primitive cd34+cd38- bone marrow stem cells
11/23/2000WO2000032221A3 Promotion or inhibition of angiogenesis and cardiovascularization
11/23/2000WO2000031283A3 Regulatory sequences useful for gene expression in plant embryo tissue
11/23/2000WO2000031124A3 Peptides that modulate the interaction of b class ephrins and pdz domains
11/23/2000WO2000028020A3 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor
11/23/2000WO2000028011A3 Fk506-based regulation of biological events
11/23/2000WO2000027994A3 Chlamydia pneumoniae genome sequence
11/23/2000WO2000026357A3 Transgenic and cloned mammals
11/23/2000WO2000026348A3 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity
11/23/2000WO2000023100A3 Genes and proteins predictive and therapeutic for renal disease and associated disorders
11/23/2000WO2000023053A3 Artificial antigen-specific cells and related methods
11/23/2000WO2000022144A3 Means and methods for modulating stomata characteristica in plants
11/23/2000WO2000020450A3 Calcium channel alpha-2/delta gene
11/23/2000WO2000017369A3 Alzheimer's disease secretase
11/23/2000WO2000015790A3 Leptin induced genes
11/23/2000WO2000015666A3 Compositions and methods for the treatment of tumors
11/23/2000WO2000012740A3 Adenoviruses deleted in the iva2, 100k and/or preterminal protein sequences
11/23/2000WO2000009666A3 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof
11/23/2000WO2000007545A3 Apoptosis proteins
11/23/2000WO1999004775A3 Method of treating dopaminergic and gaba-nergic disorders
11/23/2000DE19922078A1 Gewebekonstrukt für die Transplantationschirurgie Tissue construct for transplantation surgery
11/23/2000DE19919124A1 Nukleinsäuremolekül, umfassend eine für ein Polypeptid mit Chorismatmutase-Aktivität kodierende Nukleinsäure Nucleic acid molecule comprising a sequence encoding a polypeptide having chorismate mutase activity nucleic acid
11/23/2000CA2374272A1 Promoter of thioredoxine tatrxh2 in wheat
11/23/2000CA2374053A1 Secreted polypeptides and corresponding polynucleotides
11/23/2000CA2374045A1 Compositions isolated from skin cells and methods for their use
11/23/2000CA2374015A1 Gene isolated from ricinus communis encoding a new protein that interacts with the oleate 12-hydroxylase enzyme
11/23/2000CA2373938A1 Compositions and methods for treating cell proliferation disorders
11/23/2000CA2373616A1 Tm4sf receptors
11/23/2000CA2373231A1 Extracellular signaling molecules
11/23/2000CA2373191A1 Full-length molecules expressed in human tissues
11/23/2000CA2372926A1 143 human secreted proteins
11/23/2000CA2372661A1 Cdx2 is downstream mediator of apc tumor suppressor activity
11/23/2000CA2372654A1 Acquired resistance genes in plants
11/23/2000CA2372541A1 Sphingosine kinase enzyme
11/23/2000CA2372534A1 Differentiated human embryoid cells and a method for producing them
11/23/2000CA2372485A1 Cell concentration and lysate clearance using paramagnetic particles
11/23/2000CA2372393A1 Novel proteins with insulin-like activity useful in the treatment of diabetes
11/23/2000CA2372323A1 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene
11/23/2000CA2372304A1 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins
11/23/2000CA2372200A1 Self-assembling biomolecular structures
11/23/2000CA2372119A1 Neuroprotective properties of gdf-15, a novel member of the tgf-.beta. superfamily
11/23/2000CA2371212A1 Differential gene expression in specific regions of the brain in neurodegenerative diseases
11/23/2000CA2369369A1 Buforin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins
11/23/2000CA2369085A1 Ex vivo expansion of mammalian hematopoietic stem cells
11/23/2000CA2368833A1 Molecules expressed in hippocampus
11/23/2000CA2368620A1 Genetic modification of male germ cells for generation of transgenic species and genetic therapies
11/22/2000EP1054065A1 A method of producing a taxane-type diterpene and method of obtaining cultured cells which produce the taxane-type diterpene at a high rate
11/22/2000EP1054064A1 Adenovirus derived gene delivery vehicles comprising at least one element of adenovirus type 35
11/22/2000EP1054055A1 Method for providing a substrate structure for oriented neuron growth, substrate structure, and device for monitoring neurons
11/22/2000EP1053757A1 Tissue scaffold for transplantation surgery
11/22/2000EP1053751A1 Compositions and methods for treating cell proliferation disorders
1 ... 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 ... 1827